Vontobel Financial Products Ltd. Stock

Certificat

RMAVJV

CH1280438552

Market Closed - Bid/Ask 11:15:01 2024-06-17 am EDT			After market 11:15:01 am
100.1 ^CHF	-0.20%		100.1	0.00%

1 month	-0.40%
3 months	+7.40%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BIOGEN INC.

Latest news about BIOGEN INC.

Immunome, Inc. Appoints Phil Tsai as Chief Technical Officer	08:00am	CI
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit	Jun. 26	PR
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen	Jun. 26	PR
Shareholders of Biogen Inc. Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB	Jun. 26	PR

More news

Static data

Product type	Obligations Convertibles
Buy / Sell	CALL
Underlying	BIOGEN INC.
Issuer	Vontobel
	RMAVJV
ISIN	CH1280438552
Date issued	2023-07-20
Strike	274.7 $
Maturity	2024-07-22 (25 Days)
Parity	0.27 : 1
Emission price	100 CHF
Emission volume	N/A
Settlement	règlement en espèces
Currency	CHF

Technical Indicators

Highest since issue	100.5 CHF
Lowest since issue	74.4 CHF
Spread	8 CHF
Spread %	0.80%

Company Profile

Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (17,2%) ; - other (9,1%): primarily revenues from partnership agreements.

Sector

More about the company